Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 6
2022 3
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

17 results

Results by year

Filters applied: . Clear all
Page 1
Malaria prophylaxis approach during COVID-19 pandemic.
Rodriguez-Valero N, Vera I, Torralvo MR, De Alba T, Ferrer E, Camprubi D, Almuedo Riera A, Gallego RS, Muelas M, Pinazo MJ, Muñoz J. Rodriguez-Valero N, et al. Among authors: almuedo riera a. Travel Med Infect Dis. 2020 Nov-Dec;38:101716. doi: 10.1016/j.tmaid.2020.101716. Epub 2020 Apr 29. Travel Med Infect Dis. 2020. PMID: 32360423 Free PMC article. No abstract available.
Telemedicine for international travelers through a Smartphone-based monitoring platform (Trip Doctor®).
Rodriguez-Valero N, Carbayo ML, Camprubí-Ferrer D, Martí-Soler H, Sanchez DC, Vladimirov A, Pinazo MJ, Almuedo-Riera A, Roman A, Vera I, Roldan M, de Alba T, Jimenez A, Gómez-Valverde JJ, Oroz ML, Muñoz J. Rodriguez-Valero N, et al. Among authors: almuedo riera a. Travel Med Infect Dis. 2022 Sep-Oct;49:102356. doi: 10.1016/j.tmaid.2022.102356. Epub 2022 May 16. Travel Med Infect Dis. 2022. PMID: 35589007
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19.
Garcia-Vidal C, Alonso R, Camon AM, Cardozo C, Albiach L, Agüero D, Marcos MA, Ambrosioni J, Bodro M, Chumbita M, de la Mora L, Garcia-Pouton N, Dueñas G, Hernandez-Meneses M, Inciarte A, Cuesta G, Meira F, Morata L, Puerta-Alcalde P, Herrera S, Tuset M, Castro P, Prieto-Gonzalez S, Almuedo-Riera A, Mensa J, Martínez JA, Sanjuan G, Nicolas JM, Del Rio A, Muñoz J, Vila J, Garcia F, Soriano A; Hospital Clinic of Barcelona COVID-19 Research Group. Garcia-Vidal C, et al. Among authors: almuedo riera a. J Antimicrob Chemother. 2021 Nov 12;76(12):3296-3302. doi: 10.1093/jac/dkab321. J Antimicrob Chemother. 2021. PMID: 34473275 Free PMC article.
Incidence of human granulocytic anaplasmosis in returning travellers with fever.
Camprubí-Ferrer D, Portillo A, Santibáñez S, Almuedo-Riera A, Rodriguez-Valero N, Subirà C, Martinez MJ, Navero-Castillejos J, Fernandez-Pardos M, Genton B, Cobuccio L, Van Den Broucke S, Bottieau E, Muñoz J, Oteo JA. Camprubí-Ferrer D, et al. Among authors: almuedo riera a. J Travel Med. 2021 Jun 1;28(4):taab056. doi: 10.1093/jtm/taab056. J Travel Med. 2021. PMID: 33839778
Causes of fever in returning travelers: a European multicenter prospective cohort study.
Camprubí-Ferrer D, Cobuccio L, Van Den Broucke S, Genton B, Bottieau E, d'Acremont V, Rodriguez-Valero N, Almuedo-Riera A, Balerdi-Sarasola L, Subirà C, Fernandez-Pardos M, Martinez MJ, Navero-Castillejos J, Vera I, Llenas-Garcia J, Rothe C, Cadar D, Van Esbroeck M, Foque N, Muñoz J. Camprubí-Ferrer D, et al. Among authors: almuedo riera a. J Travel Med. 2022 Mar 21;29(2):taac002. doi: 10.1093/jtm/taac002. J Travel Med. 2022. PMID: 35040473
Skin Manifestations in COVID-19: Prevalence and Relationship with Disease Severity.
Giavedoni P, Podlipnik S, Pericàs JM, Fuertes de Vega I, García-Herrera A, Alós L, Carrera C, Andreu-Febrer C, Sanz-Beltran J, Riquelme-Mc Loughlin C, Riera-Monroig J, Combalia A, Bosch-Amate X, Morgado-Carrasco D, Pigem R, Toll-Abelló A, Martí-Martí I, Rizo-Potau D, Serra-García L, Alamon-Reig F, Iranzo P, Almuedo-Riera A, Muñoz J, Puig S, Mascaró JM Jr. Giavedoni P, et al. Among authors: almuedo riera a. J Clin Med. 2020 Oct 12;9(10):3261. doi: 10.3390/jcm9103261. J Clin Med. 2020. PMID: 33053817 Free PMC article.
Lack of efficacy of standard doses of ivermectin in severe COVID-19 patients.
Camprubí D, Almuedo-Riera A, Martí-Soler H, Soriano A, Hurtado JC, Subirà C, Grau-Pujol B, Krolewiecki A, Muñoz J. Camprubí D, et al. Among authors: almuedo riera a. PLoS One. 2020 Nov 11;15(11):e0242184. doi: 10.1371/journal.pone.0242184. eCollection 2020. PLoS One. 2020. PMID: 33175880 Free PMC article.
Tocilizumab reduces the risk of ICU admission and mortality in patients with SARS-CoV-2 infection.
Moreno-García E, Rico E, Albiach L, Agüero D, Ambrosioni J, Bodro M, Cardozo C, Chumbita M, De la Mora M, García-Pouton N, Garcia-Vidal C, González-Cordón A, Hernández-Meneses M, Inciarte A, Laguno M, Leal L, Linares L, Macay I, Meira F, Mensa J, Moreno A, Morata L, Puerta-Alcalde P, Rojas J, Solá M, Torres B, Torres M, Tomé A, Tuset M, Castro P, Fernández S, Nicolás JM, Almuedo-Riera A, Muñoz J, Fernandez-Pittol M, Marcos MA, Soy D, Martínez JA, García F, Soriano A. Moreno-García E, et al. Among authors: almuedo riera a. Rev Esp Quimioter. 2021 Jun;34(3):238-244. doi: 10.37201/req/037.2021. Epub 2021 Apr 7. Rev Esp Quimioter. 2021. PMID: 33829722 Free PMC article.
17 results